In the 1830s, Scottish surgeon Robert Liston was famed for his rapid amputations, crucial before the advent of anesthesia. This video traces the evolution of anesthetics from ancient…
A recent publication in Interventional Pain Medicine, authored by Rohan Jotwani, MD, MBA, of Brigham and Women’s Hospital, Harvard Medical School in Boston, MA, and colleagues, demonstrates the…
Pompe disease is a rare, life-threatening genetic disorder caused by GAA enzyme deficiency, leading to glycogen buildup and muscle cell destruction. It presents on a spectrum, from infantile-onset…
Pompe disease is a progressive, life-threatening genetic neuromuscular disorder. Late-onset Pompe disease (LOPD), affecting individuals over one year old, leads to trunk and proximal muscle weakness, often impacting…
Sandra, diagnosed with late-onset Pompe disease, shares her journey of resilience and determination. Despite experiencing symptoms like muscle weakness and difficulty with daily activities since her 30s, she…
In this webinar, we delve into the advancements in Pompe disease treatment, particularly focusing on the progression from mouse models to clinical trials. Key developments include the testing…
Dr. Tahseen Mozaffar, clinical professor of neurology at the University of California Irvine, presents a webinar on Pompe Disease. Learn about the latest advancements in diagnosis, treatment options,…
This video dives into Pompe Disease, also known as Glycogen Storage Disease Type 2. The host explains the key components of this disease, where the body cannot break…